NASDAQ: GCTK
GlucoTrack, Inc.
Healthcare · Medical - Instruments & Supplies
Per-share valuation inputs need verification
Event dated Jun 30, 2026Market-derived shares outstanding and recent statement shares differ materially. Per-share ratios and valuation outputs may be unreliable until the share base is verified. This sometimes appears with ADRs or provider share-count gaps.
Market Cap
$2.64M
52w High
$14.14
52w Low
$0.25
P/E
-0.04
Volume
22.30M
Outstanding Shares
7.72M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 93.8% over the last year. Free cash flow declined 31.06% over the trailing twelve months.
What the market seems to be pricing
The market appears to be responding to weaker operating momentum rather than only rerating the stock.
What would invalidate this read
Free cash flow fell 31.06% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems.
Valuation
Stock splits
Every 60 shares became 1
Every 5 shares became 1
Every 13 shares became 1
Profitability & growth
Analyst consensus
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 14, 2026
Q4 FY26 · EPS est — · Revenue est —
View